Drug Trial Radar · NCT05763121
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
Last checked: Nov 19, 2026Latest source record: Dec 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,061
Actual
Start
Jan 30, 2023
Primary completion
Dec 8, 2025
Study completion Dec 8, 2025
Sponsor
- Lead sponsor
- Areteia TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 10, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma with an eosinophilic phenotype and a history of asthma exacerbations.
Conditions
- Eosinophilic Asthma
- Asthma; Eosinophilic
- Asthma
Interventions
Dexpramipexole DihydrochlorideDrug
oral administration of dexpramipexole tablet
PlaceboDrug
oral administration of placebo tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized rate of severe asthma exacerbations over 52 weeks.Time frame: Day 1 (baseline, pre-dose) through Week 52
Locations
401 sites in 20 countries. Site status is shown where the registry gives one.
Research Site 20001-374
Bakersfield, California
Research Site 20001-440
La Palma, California
Research Site 20001-062
Newport Beach, California
Research Site 20001-043
Newport Beach, California
Research Site 20001-380
Redding, California
Research Site US-20001-488
San Diego, California
Research Site 20001-003
West Covina, California
Research Site 20001-419
Westminster, California
Research Site 20001-048
Aventura, Florida
Research Site 20001-005
Brandon, Florida
Research Site 20001-051
Brandon, Florida
Research Site 20001-029
Coral Gables, Florida
Research Site 20001-350
Gainesville, Florida
Research Site 20001-014
Green Acres, Florida
Research Site 20001-054
Hialeah, Florida
Research Site 20001-067
Hialeah, Florida
Research Site 20001-020
Homestead, Florida
Research Site 20001-015
Kissimmee, Florida
Research Site 20001-002
Kissimmee, Florida
Research Site 20001-086
Loxahatchee Groves, Florida
Research Site 20001-066
Miami, Florida
Research Site 20001-001
Miami, Florida
Research Site 20001-059
Miami, Florida
Research Site 20001-026
Miami, Florida
Research Site 20001-065
Miami, Florida
Research Site 20001-024
Miami, Florida
Research Site 20001-069
St. Petersburg, Florida
Research Site 20001-004
Tampa, Florida
Research Site 20001-075
Augusta, Georgia
Research Site 20001-018
Columbus, Georgia
Research Site 20001-459
Sugar Hill, Georgia
Research Site 20001-090
Berwyn, Illinois
Research Site 20001-476
Chicago, Illinois
Research Site 20001-358
Normal, Illinois
Research Site 20001-135
River Forest, Illinois
Research Site 20001-403
Skokie, Illinois
Research Site 20001-036
Elwood, Indiana
Research Site 20001-044
Evansville, Indiana
Research Site 20001-021
Iowa City, Iowa
Research Site 20001-019
Owensboro, Kentucky
Showing 40 of 401 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.